Labshake search
Citations for R&D Systems :
351 - 400 of 2683 citations for Recombinant Human Long Arg3 Insulin like Growth Factor I since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2022Quote: ... and recombinant human IFNγ (2 IU/mL, R&D Systems, 285IF) for 16-20 hours ...
-
bioRxiv - Cell Biology 2022Quote: ... or recombinant human Protein S (R&D Systems, Cat# 9489-PS) with 2.5 mM CaCl2 for 1.5 h ...
-
bioRxiv - Immunology 2021Quote: ... and recombinant human IL-1β (5 units/mL; R&D Systems) in the presence or absence of PAD2/PAD4 inhibitor (5 μM YW3-56 ...
-
bioRxiv - Immunology 2021Quote: ... and recombinant human IL-1β (50 units/mL; R&D Systems) and harvest for citrullination detection as described above.
-
bioRxiv - Cancer Biology 2020Quote: ... and 5 ng/ml recombinant human TGF-β (R&D Systems). After 72 h ...
-
bioRxiv - Developmental Biology 2019Quote: ... 4 ng human recombinant IGF2 (292-G2-050, R&D Systems) was used as positive control ...
-
bioRxiv - Neuroscience 2019Quote: ... 100ng/ml recombinant human sonic hedgehog (C24II, SHH, R&D system); From day 12 to the end of the differentiation ...
-
bioRxiv - Cell Biology 2019Quote: ... recombinant human FGF basic146 aa (10 ng/ml, R&D Systems), and recombinant human FGF10 (25 ng/ml ...
-
bioRxiv - Immunology 2020Quote: ... Recombinant human and mouse IFNγ were purchased from R&D Systems. FLAG-STAT1 (Addgene #71454 ...
-
bioRxiv - Cell Biology 2019Quote: ... VEGFR-2 and recombinant human Heparanase were from R&D Systems Inc ...
-
bioRxiv - Immunology 2020Quote: ... and recombinant human Ace-2 (R&D Systems #933-ZN-010) were diluted in OptiMEM to the desired concentrations ...
-
bioRxiv - Bioengineering 2021Quote: ... MCF10A cells were treated with human recombinant TGFβ1 (R&D Systems) for 2 weeks.
-
bioRxiv - Neuroscience 2020Quote: ... Human recombinant TDP-43/TARDBP protein (R&D systems, MN, US) was reconstituted as per manufacturer’s instruction ...
-
bioRxiv - Cell Biology 2021Quote: ... GM6001 (Selleckchem, Munich, Germany) or recombinant human TIMP1 (R&D Systems).
-
bioRxiv - Cancer Biology 2021Quote: ... 100ng/mL recombinant human Reelin (R&D Systems, #8546-MR-050) and mouse Reelin (R&D Systems ...
-
bioRxiv - Immunology 2021Quote: ... and 30 IU/ml recombinant human IL-2 (R&D Systems). Prior to transduction with VSVGwt viruses ...
-
bioRxiv - Neuroscience 2022Quote: ... and recombinant human NOTCH3 ECD (1559-NT-050; R&D Systems) was used as standard protein ...
-
bioRxiv - Cell Biology 2022Quote: ... 10 ng/ml recombinant human BMP9 and BMP10 (R&D Systems), or 5 μm cytochalasin B (Sigma-Aldrich).
-
bioRxiv - Developmental Biology 2023Quote: ... 10 ng/mL recombinant human BMP4 (R&D Systems, 314-BP), and 50nM retinoid acid (Sigma-Aldrich ...
-
bioRxiv - Immunology 2022Quote: ... Recombinant human PD-L1 protein (R&D Systems, Cat# 156-B7) was used to make the standard curve ranging from 0.3125 to 10 ng/ml.
-
bioRxiv - Microbiology 2023Quote: ... or 1 μg of human recombinant Gas6 protein (R&D Systems) prior to K ...
-
bioRxiv - Neuroscience 2023Quote: ... human recombinant GDF15 (10 ng/ml; R&D Systems, 9279-GD), human recombinant EGF (20 ng/ml ...
-
bioRxiv - Cancer Biology 2023Quote: ... Th1 condition: Recombinant human IFNγ (10 ng/ml, R&D Systems), and IL-12 (10 ng/ml ...
-
bioRxiv - Microbiology 2023Quote: ... 50 pmol of recombinant human CXCL1 or CXCL8 (R&D Systems) was incubated with C-terminal SpyCEP in a final volume of 20 μl ...
-
bioRxiv - Bioengineering 2023Quote: ... 10000 ng/mL of recombinant human VEGF-A (R&D Systems) for 12 hours at 4°C on a tube rotator ...
-
bioRxiv - Cancer Biology 2023Quote: ... 40ng/mL recombinant human FGF (R&D systems, 100-18B-100), 0.5 × B27 serum free supplement (ThermoFisher Scientific ...
-
bioRxiv - Immunology 2023Quote: ... with or without 200ng/mL recombinant human BAFF (R&D Systems). After overnight culture ...
-
bioRxiv - Developmental Biology 2023Quote: ... 10ng/mL recombinant human FGF7 (R&D Systems, Cat#251-KG), and 3µM CHIR99021 (APExBIO ...
-
bioRxiv - Microbiology 2023Quote: ... 1 µg/mL recombinant human R-spondin-1 (R&D systems), 500 nM A83-01 (R&D systems) ...
-
bioRxiv - Microbiology 2023Quote: ... 1 µg/mL recombinant human R-spondin-1 (R&D systems), 500 nM A83-01 (R&D systems) ...
-
bioRxiv - Biochemistry 2023Quote: Recombinant human pro-ISG15 protein (R&D Systems, #UL-615-500) was diluted in EMBO lysis buffer (50mM Tris-HCl pH 7.4 ...
-
bioRxiv - Biochemistry 2023Quote: ... and Ub-Propargyl (recombinant human) were purchased from R&D systems. DNA for Smurf1 ...
-
bioRxiv - Bioengineering 2023Quote: ... and 20 ng/mL human recombinant FGF-4 (R&D Systems). After 9 to 13 days ...
-
bioRxiv - Immunology 2024Quote: Recombinant human IL-2 (Proleukin) was purchased from R&D Systems or obtained from the National Cancer Institute’s Biological Research Branch ...
-
bioRxiv - Bioengineering 2023Quote: ... with 20 ng/mL human recombinant Oncostatin M (R&D Systems). On differentiation day 25 ...
-
bioRxiv - Neuroscience 2024Quote: ... Recombinant human legumain/asparginyl endopeptidase (# 2199-CY-010, R&D Systems) was used as a standard (18.31 to 2343.75 pg/ml) ...
-
bioRxiv - Cancer Biology 2024Quote: ... and recombinant human IL-7 (5 ng/mL) (R&D Systems).
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL recombinant human EGF (R&D system; 236-EG), 0.5 µM A 83-01 (R&D Systems ...
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL recombinant human EGF (R&D system; 236-EG), 0.5 µM A 83-01 (R&D Systems ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/ml recombinant human VEGF 165 protein (R&D Systems), 10 ng/ml human bFGF (Invitrogen) ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/mL recombinant human VEGF 165 Protein (R&D Systems) and 0.25 ng/mL recombinant human BMP-4 Protein (R&D Systems).Cells were cultured for 28 hours ...
-
bioRxiv - Neuroscience 2021Quote: ... The medium was supplemented with 20 ng/ml epidermal growth factor (EGF, #236-EG; R&D Systems) and 20 ng/ml basic fibroblast growth factor (bFGF ...
-
bioRxiv - Cancer Biology 2019Quote: ... medium was supplemented with a growth factor cocktail for recovery (100 ng/ml EGF (R&D Systems), 100 ng/ml FGF1 (R&D Systems) ...
-
bioRxiv - Bioengineering 2020Quote: ... resuspended in complete culture media supplemented with 0.25 μg/mL neural growth factor (NGF, R&D Systems) and 0.1 μg/mL Ciliary Neurotrophic Factor (CNTF ...
-
bioRxiv - Bioengineering 2020Quote: ... 2) transforming growth factor beta-2 (TGF-β2; 2.5 ng/ml; R&D Systems, Minneapolis, MN, USA), 3 ...
-
bioRxiv - Neuroscience 2019Quote: ... goat anti-platelet derived growth factor receptor-α (PDGFRα, 1:200, AF1062. R&D Systems, MN, USA), goat anti-Iba1 (1:200 ...
-
bioRxiv - Cell Biology 2021Quote: ... and the respective growth factors and small molecules (8 µM GSK-3 inhibitor CHIR99021 (R&D Systems), 200 ng/mL FGF9 (fibroblast growth factor 9 ...
-
bioRxiv - Cancer Biology 2023Quote: ... All growth factors and most small molecules used for hESC differentiation were purchased from R&D Systems. ATRA ...
-
bioRxiv - Cancer Biology 2023Quote: ... Organoids were maintained in CultrexTM UltiMatrix Reduced Growth Factor Basement Membrane Extract (BME001-10, R&D Systems) and incubated in Advanced DMEM/F12 (12-634-010 ...
-
bioRxiv - Cell Biology 2024Quote: ... and 125 ng/mL Fibroblast growth factor (FGF) -8b (423-F8-025/CF; R&D Systems Inc) to DPSC-BM as previously reported [35] ...